TY - JOUR
T1 - Mechanochemical Synthesis of Carvedilol Cocrystals Utilizing Hot Melt Extrusion Technology
AU - Fernandes, Gasper J.
AU - Rathnanand, Mahalaxmi
AU - Kulkarni, Vijay
N1 - Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Purpose: To improve the solubility of carvedilol by preparing cocrystals utilizing solvent-free, continuous technology hot melt extrusion. Methods: Cocrystals of carvedilol and nicotinamide were formed in 1:2 ratio using hot melt extrusion (HME) by altering the parameters associated with the temperature of barrels and screw speed of the shaft. The product was characterized by DSC, PXRD, and FTIR, while the morphology was determined by SEM. Saturation solubility studies and dissolution rate were compared with carvedilol. Results: The processing parameters in HME significantly affected the cocrystallization which improved on changing the temperature and screw speed (cocrystals were formed when the temperature was set above the eutectic melting point). The obtained carvedilol cocrystals showed a distinct difference in morphological characteristics as compared to pure drug. The cocrystals showed the presence of additional peaks in DSC thermograph as well as band shifts in infrared spectrum. The powder XRD of cocrystals showed the difference in the 2θ values as compared with carvedilol indicating an interaction between carvedilol and nicotinamide. The saturation solubility studies and in vitro dissolution studies showed of cocrystals showed an increase in solubility and drug release, respectively, in 0.1N HCl. Conclusion: Hence, cocrystallization utilizing HME marks an important advantage over other conventional techniques. A single step, continuous process, scalable, and solvent-free HME process proved to be the best method to produce cocrystals on a larger scale with maximum yield. However, to further decrease the number of manufacturing steps, efforts are being made to combine crystallization and formulation in a single step.
AB - Purpose: To improve the solubility of carvedilol by preparing cocrystals utilizing solvent-free, continuous technology hot melt extrusion. Methods: Cocrystals of carvedilol and nicotinamide were formed in 1:2 ratio using hot melt extrusion (HME) by altering the parameters associated with the temperature of barrels and screw speed of the shaft. The product was characterized by DSC, PXRD, and FTIR, while the morphology was determined by SEM. Saturation solubility studies and dissolution rate were compared with carvedilol. Results: The processing parameters in HME significantly affected the cocrystallization which improved on changing the temperature and screw speed (cocrystals were formed when the temperature was set above the eutectic melting point). The obtained carvedilol cocrystals showed a distinct difference in morphological characteristics as compared to pure drug. The cocrystals showed the presence of additional peaks in DSC thermograph as well as band shifts in infrared spectrum. The powder XRD of cocrystals showed the difference in the 2θ values as compared with carvedilol indicating an interaction between carvedilol and nicotinamide. The saturation solubility studies and in vitro dissolution studies showed of cocrystals showed an increase in solubility and drug release, respectively, in 0.1N HCl. Conclusion: Hence, cocrystallization utilizing HME marks an important advantage over other conventional techniques. A single step, continuous process, scalable, and solvent-free HME process proved to be the best method to produce cocrystals on a larger scale with maximum yield. However, to further decrease the number of manufacturing steps, efforts are being made to combine crystallization and formulation in a single step.
UR - http://www.scopus.com/inward/record.url?scp=85056168184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056168184&partnerID=8YFLogxK
U2 - 10.1007/s12247-018-9360-y
DO - 10.1007/s12247-018-9360-y
M3 - Article
AN - SCOPUS:85056168184
SN - 1872-5120
VL - 14
SP - 373
EP - 381
JO - Journal of Pharmaceutical Innovation
JF - Journal of Pharmaceutical Innovation
IS - 4
ER -